Adjuvant Metronomic CMF in a Contemporary Breast Cancer Cohort: What’s Old is New

Commonly used adjuvant systemic therapies harbor high rates of severe short-term and long-term side effects but are often justified to patients because of curative intent in early stage breast cancer. One of the oldest and least toxic adjuvant regimens, oral cyclophosphamide given with intravenous m...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Breast Cancer
Autori principali: Cho, Eunpi, Schwemm, Ann, Rubinstein, Lena, Stevenson, Phillip, Gooley, Ted A., Ellis, Georgiana, Specht, Jennifer M., Livingston, Robert B., Linden, Hannah M., Gadi, Vijayakrishna K.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4568144/
https://ncbi.nlm.nih.gov/pubmed/26025883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clbc.2015.04.002
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi